Jiang; Jiahua

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jiang; Jiahua.The latest application filed is for "anti-cd40 antibody, antigen binding fragmentand pharmaceutical use thereof".

Company Profile

10.3.12

Jiang; Jiahua - Shanghai CN
JIANG; Jiahua - Lianyungang CN
Jiang; Jiahua - Jiangsu CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
PD-L1 antibody, antigen-binding fragment thereof, and pharmaceutical use thereof Grant 11,359,021 - Gu , et al. June 14, 2	2022-06-14
Anti-cd40 Antibody, Antigen Binding Fragmentand Pharmaceutical Use Thereof App 20220025060 - LIAO; Cheng ; et al.	2022-01-27
Anti-4-1bb Antibody, Antigen-binding Fragment Thereof And Medical Use Thereof App 20210363266 - HUANG; Hao ; et al.	2021-11-25
An Anti-ox40 Antibody, Antigen-binding Fragment Thereof, And The Pharmaceutical Use App 20210355229 - Liao; Cheng ; et al.	2021-11-18
Human Il-4r Binding Antibody, Antigen Binding Fragment Thereof, And Medical Use Thereof App 20210238294 - LIAO; Cheng ; et al.	2021-08-05
Use of combination of VEGFR inhibitor and PARP inhibitor in preparation of medicament for treating gastric cancer Grant 11,000,518 - Jiang , et al. May 11, 2	2021-05-11
Anti-CD27 Antibody, Antigen-binding Fragment Thereof, and Medical Use Thereof App 20210009706 - Huang; Hao ; et al.	2021-01-14
Method for preventing or treating tumor diseases with a combination of tyrosine kinase inhibitor and CDK4/6 inhibitor Grant 10,857,146 - Jiang , et al. December 8, 2	2020-12-08
Pd-l1 Antibody, Antigen-binding Fragment Thereof, And Pharmaceutical Use Thereof App 20200339692 - GU; Xiaoling ; et al.	2020-10-29
Anti-cd40 Antibody, Antigen Binding Fragment Thereof And Medical Use Thereof App 20200148778 - Yan; Shude ; et al.	2020-05-14
Anti-gitr Antibody, Antigen-binding Fragment Thereof, And Pharmaceutical Use Thereof App 20200131263 - YAN; Shude ; et al.	2020-04-30
Method For Preventing Or Treating Tumor Diseases With A Combination Of Tyrosine Kinase Inhibitor And Cdk4/6 Inhibitor App 20200061049 - Jiang; Jiahua ; et al.	2020-02-27
Medical Use Of Anti-c Met Antibody-cytotoxic Drug Conjugate App 20200054764 - SUN; Xing ; et al.	2020-02-20
Use Of Combination Of Vegfr Inhibitor And Parp Inhibitor In Preparation Of Medicament For Treating Gastric Cancer App 20190275021 - JIANG; Jiahua ; et al.	2019-09-12
Anti-cd27 Antibody, Antigen-binding Fragment Thereof, And Medical Use Of Same App 20190225698 - YAN; Shude ; et al.	2019-07-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.